. The inhibition of proteolysis and of cathepsin B was reversed virtually completely within 24 h, when the inhibitor was removed from the medium. Since the inhibitor forms a covalent bond with the enzyme, the recovery of cathepsin B activity presumably reflects production of new molecules of active enzyme. 5. The inhibitory effects of pepstatin, the carboxyl proteinase inhibitor, were under some circumstances additive with those of Z-Phe-Ala-CHN2, and were also largely reversible. 6. It is concluded that thiol proteinases play a major role in lysosomal proteolysis in cultured macrophages.
Evidence has accumulated which indicates that lysosomes are involved in the degradation of intracellular proteins in many cells (Dean, 1975; Dean & Barrett, 1976; Goldberg & St. John, 1976; Amenta et al., 1977 Amenta et al., , 1978 Ballard, 1978) . Much of the evidence has concerned inhibition of degradation by various agents such as proteinase inhibitors, in particular pepstatin, directed to the lysosomal system (Dean, 1975) . In most experimental work the organ or cells concerned have been studied under conditions of nutritional and hormonal deprivation in which proteolysis is 'accelerated' above the 'basal' rates which obtain in nutritionally and hormonally supplemented conditions (see Goldberg & St. John, 1976) . Several authors have therefore argued that lysosomes may be involved only in the 'accelerated' proteolysis. However, Dean (1979) has presented some work on protein degradation in cultured mouse macrophages in which pepstatin, entering the cells Abbreviation used: Z-Phe-Ala-CHN2, benzyloxycarbonylphenylalanylalanyldiazomethane (benzyloxycarbonylphenylalanylalanine diazomethyl ketone).
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Until recently, pepstatin seemed to be the only proteinase inhibitor with sufficient group-specificity and effectiveness to allow the demonstration of participation of proteinases of particular catalytic groups in intracellular proteolysis. Thus previous conclusions on lysosomal proteolysis have largely concerned the participation of carboxyl proteinases, particularly cathepsin D (susceptible to pepstatin). However, thiol proteinases are possibly even more potent than carboxyl proteinases in lysosomal proteolysis (see Barrett, 1977) . Therefore the present paper describes the effects on macrophage basal proteolysis of a new synthetic inhibitor, Z-Phe-Ala-CHN2, which is selectively active on thiol proteinases. The inhibition of proteolysis is correlated with the inhibition of intracellular cathepsin B. 10mg/ml, and was diluted from this stock into media at the specified concentration. Methanol was used at a maximum concentration of 1% (v/v) in the cultures and had no effect on proteolysis, although it slightly accelerated cell death.
Z-Phe-Ala-CHN2 was synthesized (Watanabe et al., 1979) by the method described for an analogous reagent . A radioactive form of this inhibitor was also prepared by using 14C-labelled diazomethane to have no effect on protein turnover or cell death. The stock solution of inhibitor was stored at 40C, but not for longer than 2 weeks. In experiments involving combinations of pepstatin and Z-Phe-Ala-CHN2, both inhibitors were made up in methanol, which was maintained at 1% (v/v) in both control cultures and those containing inhibitors. Z-PheAla was obtained from Sigma. Partially purified cathepsin D and highly purified cathepsin B, both from human liver, were kind gifts from Dr. A. J. Barrett (Strangeways Research Laboratory, Cambridge, U.K.).
Assays
Papain was measured by an esterase assay . Cathepsin D was measured by method 1 described by Barrett & Heath (1977) , at 370C, with haemoglobin as substrate. One unit of enzyme causes an increase in A280 of the trichloroacetic acidsoluble materials of 1, in a 1 h incubation under assay conditions. Cathepsin B was assayed against benzyloxycarbonylarginylarginine 2-naphthylamide, followed by Fast Garnet GBC coupling of the product (Barrett, 1972) . We are grateful to Dr. C. G. Knight (Strangeways) for a sample of this substrate. Protein was measured by the procedure of Lowry et al. (1951) , with bovine serum albumin as standard.
Macrophage collection and culture
The methods employed have been described in detail previously (Dean, 1979) . The cells (from normal TO mice) were cultivated in Medium 199 containing 10% (v/v) heat-inactivated acid-treated foetal calf serum, with 100 international units of penicillin/ml and 100,ug of streptomycin/ml. The acid treatment (pH 3, 30 min) was used to destroy some proteinase inhibitors (Werb & Gordon, 1975) . After establishment of the cultures overnight (in 2cm2 Linbro culture wells, with 2 ml of medium) the medium was changed to leucine-free modified Eagle's Medium with 10% (v/v) heat-inactivated acidtreated foetal calf serum, containing 0.1,uCi of L-[U-14C]leucine/ml. After 24h, the cells were washed four times with phosphate-buffered saline (comprising 136mM-NaCl, 2.7mM-KCl, 8.1 mmNa2HPO4 and 1.5 mM-KH2PO4, without Ca2+ and Mg2+), containing 10mM-leucine. This washing procedure was found to deplete the cells satisfactorily of radioactive low-molecular-weight substances such as free amino acids); less than 4% of the radioactivity in the cells was found to be soluble in 5% (w/v) trichloroacetic acid. The macrophages then received fresh modified Eagle's medium with serum as before, and with 10mM-leucine (unlabelled). This concentration of leucine has been shown previously to suppress reutilization of radioactive leucine (Dean, 1979) . Inhibitors or solvents were added to the medium as indicated in the Results section. All experiments were performed with at least triplicate cultures, and were repeated several times. After various periods of further culture, medium was removed for measurement of radioactivity; 0.5 ml was treated with 0.5 ml of 10% trichloroacetic acid/ 100mM-leucine. After centrifugation (200g for 5 min), 0.5 ml of the supernatant was removed for radioactivity counting. The precipitate was washed twice with 5% trichloroacetic acid/ 10 mM-leucine, and dissolved in 1 ml of 99% formic acid; 0.5 ml of the solution was removed for radioactivity counting.
The cells remaining on the plate were scraped off with two 0.5 ml portions of 0.1% (v/v) Triton X-100, unless cathepsin B was to be measured. In that case 50mM-sodium acetate buffer, pH 5.0, was used, since cathepsin B is unstable at neutral pH (Barrett, 1977) . For radioactivity counting, 0.5 ml of extract, plus 501 of 10% bovine serum albumin, were treated with 0.5 ml of 10% trichloroacetic acid/100mM-leucine, as described above for the medium, and the processing was continued to provide samples of the cellular trichloroacetic acidsoluble and insoluble fractions for radioactivity counting.
Standards were counted for radioactivity in 1980 aqueous trichloroacetic acid and in formic acid to measure counting efficiency for appropriate correction. A Triton X-100/toluene scintillant (3:7, v/v) was used. Results are expressed as percentage degradation (±S.D.), which is computed as trichloroacetic acid-soluble radioactivity as a percentage of total radioactivity in the system. Trichloroacetic acid-precipitable material in the medium gave an upper estimate of the amount of cell death occurring in the cultures. All the data quoted in the Results section are from experiments conducted with triplicate observations for each condition.
Results and Discussion
The major proteolytic enzymes responsible for lysosomal protein degradation are probably thiol proteinases (such as cathepsins B and L) and carboxyl proteinases such as cathepsin D (see Barrett, 1977) . In establishing the group selectivity of peptidyl diazomethyl ketones for the inactivation of thiol proteinases, a lack of action on chymotrypsin, a representative serine proteinase, had been shown (H. Watanabe, G. Green & E. Shaw, unpublished work). However, a possible effect on cathepsin D, a representative carboxyl proteinase, had not been examined. For this purpose cathepsin D (9units/ml) was incubated at 37°C with 50pM-Z-Phe-Phe-CHN2 at pH 5.0 for 1 h. No loss of ability to digest haemoglobin was observed beyond that of the control sample in the same solvent (20% dimethyl sulphoxide). This loss of activity against haemoglobin was always less than 10%.
In preparation for its use under conditions of cell culture, the stability of Z-Phe-Ala-CHN2 was examined. The inhibitor was incubated in complete medium at 10pUM at 370C. Samples were diluted to 0. 1pM and examined for ability to inactivate papain. It was estimated that incubation for 2 days resulted in a minor loss of activity, about 15%. For use with macrophages, therefore, replenishment of medium with fresh inhibitor was not considered necessary.
Various concentrations of Z-Phe-Ala-CHN2 were added to cultures of macrophages which had been incubated with ['4C]leucine as described in the Materials and Methods section, and the effect on protein turnover-was examined. Inhibition of protein turnover was consistently observed when Z-PheAla-CHN2 was present in the range 10-1OOuM, and was dose-dependent ( Fig. 1) . At 100pM, after 24h, inhibition of protein degradation generally reached 20-35% (Table 1 , Expt. lb), depending on the batch of macrophages. Even at earlier times such as 6-10 h (Table 1, Expts. la and 2), some inhibition was evident, and it increased in individual experiments as the duration of exposure was increased, up to a maximum at which it remained roughly constant for some time (see Table 2 ). Pepstatin, the group- Concn. of Z-Phe-Ala-CHN2 (,M) Fig. 1 . Dose dependence ofinhibition of macrophage protein degradation by Z-Phe-Ala-CHN2 Prelabelled cells were allowed to degrade protein for 24h in the presence of the specified concentrations of inhibitor. All culture media contained 0.2% dimethyl sulphoxide. *, Protein degradation (% of total prelabelled protein); 0, inhibition of degradation (%). specific inhibitor for carboxyl proteinases (see Umezawa & Aoyagi, 1977) , was examined in combination with lOOpM-Z-Phe-Ala-CHN2 to determine whether an increased inhibitory effect resulted.
At 20,ug/ml, pepstatin did not in these experiments have a statistically significant effect on protein degradation by itself, but it enhanced the action of Z-Phe-Ala-CHN2 whether measured at 6h ( Dean, 1979) , and the combination was again more effective (Table 1 , Expt. 4). The variability of susceptibility of the macrophages to inhibition by the added inhibitors has been discussed previously (Dean, 1979) .
In view of the inhibition of protein turnover in macrophages incubated in Z-Phe-Ala-CHN2, it was decided to examine the intracellular thiol proteinase activity in the hope of correlating the observed metabolic effect with the actual enzyme activity. Initial attempts to measure the kinetics of inactivation gave the impression that the process was proceeding very rapidly. For example, when cells were exposed to 100#uM-inhibitor for 2min, washed four times with phosphate-buffered saline, and extracts assayed for cathepsin B activity, only 8% of the activity in control cultures could be recovered. It was appreciated that free inhibitor on the surface of the cells, or internalized but not accessible to the lysosomal contents, might inactivate cathepsin B during the rupture of the cells and the long assay (about 20h) required because of the low enzyme activities available for study. Some indication of this was seen in the fact that, with accelerated cell processing and increased substrate concentration (1.5-fold) in the assay allowing a briefer incubation, an estimate of 64% inactivation after a 5 min exposure to the inhibitor could be made, in contrast with the estimate of about 90% made with normal techniques.
A radioactive form of the inhibitor was syntheVol. 186 When macrophages were exposed to lOO,uM-inhibitor containing 5.89 x 106 d.p.m./,umol, there was an association of 84pmol/lOO,ug of cellular protein within 5min, and this did not significantly change during the first h, but increased to 169 pmol at 6 h and 305pmol at 24h. To examine the possibility that some proportion of the inhibitor was adsorbed on the surface of the cells, after five washes of the cells with phosphate-buffered saline, non-radioactive inhibitor at 100puM was added to the phosphatebuffered saline for a six wash of the cells. The radioactivity appearing in the wash was double that of a sixth wash without inhibitor, indicating a displaceable population of inhibitor molecules.
In order to remove this adsorbed inhibitor, a washing procedure was developed, using the dipeptide derivative Z-Phe-Ala. Macrophages were exposed to labelled inhibitor (100,UM) for 5min. The cultures were then washed four times, with a 5 min incubation at 370C for each washing. Three different washing media were compared: phosphatebuffered saline, culture medium, and culture medium containing 1 mM-Z-Phe-Ala. Far more radioactivity was displaced by medium containing Z-Phe-Ala than by the other washing media, and by the fifth wash with Z-Phe-Ala the radioactivity removed was not significantly above background, whereas significant amounts of radioactivity were still appearing in the other washing fluids. culture medium containing 1 mM-Z-Phe-Ala, the amounts of inhibitor left associated with the cells (per 100,ug of cell protein) were respectively 45 pmol, 35 pmol and 13 pmol. Washing with Z-PheAla was found to be as efficient in serum-free medium as in serum-containing medium. Therefore, for subsequent experiments on uptake of inhibitor and on the kinetics of inhibition of intracellular cathepsin B, four washes with lmM-Z-Phe-Ala in serum-free medium, with 5min at 370C for each wash, were used.
By this procedure it was established that radioactivity fixed to the cells, presumably mainly internalized, represented 13 pmol/100,ug of cell protein in the early minutes, progressing gradually to 49pmol/100,ug of cell protein after 18h. The slowuptake phase is suggestive of entry by pinocytosis, rather than permeation, which is normally a more rapid process. It is very difficult to prove this conclusively. However, at 40C the slow uptake of inhibitor is virtually completely suppressed, as is pinocytosis. Thus internalized inhibitor is probably present in endocytic vesicles, and after fusion of these vesicles with lysosomes (see Dean & Barrett, 1976) in secondary lysosomes (as is also indicated by the observed inhibition of cathepsin B; see below).
Thus approx. 50pmol of Z-Phe-Ala-CHN2/lOOUg of cell protein was firmly associated with the cells after 24 h. Because of the small amount of uptake, and its likely predominant localization in lysosomes, it is unlikely that general effects on extralysosomal metabolism were induced. The endocytic index for uptake (see Pratten et al., 1978) was 0.02-0.05,ul/h per 106 cells. Assuming that 106 macrophages have a total volume of 1 ,1 (Pofit & Strauss, 1977) , and that lysosomes occupy 1% of that volume (see discussion in Dean, 1977) , the intralysosomal concentration of Z-Phe-Ala-CHN2 might attain several mm by 24 h. It remains possible that some inhibitor molecules might be lost by inactivation. Exocytosis of free inhibitor is unlikely, because of the covalent nature of the bond formed between it and thiol proteinases, but exocytosis of enzyme-inhibitor complexes could conceivably occur. Because of these complications, the estimate of intralysosomal concentration must be taken as very approximate.
Removal of the adsorbed inhibitor from macrophages by washes with 1 mM-Z-Phe-Ala as described now permitted a more accurate determination of the rate of inactivation of cathepsin B intracellularly. After exposure to 100lM-Z-Phe-Ala-CHN2 for 5, 30, 60 and 90min and washing with ZPhe-Ala, the macrophage content of cathepsin B fell to 72, 40, 25 and 5% of control respectively. A halftime of inactivation of about 25 min was estimated to result on incubation of macrophages with this concentration of inhibitor.
In the studies described above on the inhibition of protein turnover by Z-Phe-Ala-CHN2, the inhibitor was introduced at the beginning of the degradative period. Under these conditions cathepsin B continues to function until completely inactivated by arrival of inhibitor, and the observed inhibition may not adequately reflect the contribution of cathepsin B to protein turnover. An additional experiment was carried out with Z-Phe-Ala-CHN2 present at 100puM during the prelabelling phase, so that, on transfer to medium permitting measurement of protein degradation, the macrophages had no active cathepsin B. The presence of inhibitor in the latter medium maintained this state, but in pretreated cultures which were then placed in control medium proteolysis reverted to higher values. Z-Phe-Ala-CHN2 inhibited degradation in pretreated cultures to a slightly greater degree than in cultures prelabelled normally (30.7 versus 26.1% inhibition, respectively; Table 3 , Expt. 2, control). The pretreated cul- Table 3 . Inhibition of macrophage protein degradation by Z-Phe-Ala-CHN2 plus pepstatin: effect ofprelabelling proteins in the presence ofZ-Phe-Ala-CHN2
Macrophage cultures were prelabelled for 24h with L-[U-_4C]leucine (0.1 Ci/ml) either in normal medium or in medium containing lOOuM-Z-Phe-Ala-CHN2. After labelling, the medium was removed and was replaced by normal degradation medium with the additions indicated under 'Degradation conditions'. Methanol was maintained at 1% (v/v) in all cultures during both the prelabelling and the degradation period of 21 h. tures actually degraded their labelled protein faster than the control cultures that had been prelabelled in the absence of inhibitor. This presumably indicates that the cells prelabelled in the presence of inhibitor accumulate labelled proteins which can then be very rapidly degraded when cathepsin B activity is recovered, as in the control group of Expt. 2, Table  3 . Virtually complete recovery of cathepsin B activity was independently confirmed under these conditions. The effects of pepstatin and Z-Phe-Ala-CHN2 were additive as before, and again were more pronounced when cells were prelabelled in the presence of Z-Phe-Ala-CHN2.
In other experiments cells were prelabelled in the presence of pepstatin (lOO,g/ml), or in the presence of both pepstatin (100lug/ml) and Z-Phe-Ala-CHN2 (100PM). When such pretreated cultures were then allowed to degrade protein in the virtual absence of inhibitors (medium changed to fresh control medium), degradation proceeded at similar rates to that in cultures which were prelabelled normally in the absence of inhibitors. Cathepsin D activity also recovered to about 75% of control during the 24h degradation period. This was determined by assaying cathepsin D in cultures exposed to pepstatin for 24 or 48 h, in cultures preincubated for 24 h in pepstatin and then incubated for a further 24 h in the absence of extracellular inhibitor (medium changed at 24 h), and in controls for each time point. When retained during the degradation period, pepstatin and Z-Phe-Ala-CHN2 suppressed proteolysis, and their effects were again approximately additive, up to a maximum inhibition of 35% (compared with pretreated cells degrading in the absence of inhibitors). It should be noted that the protein labelling in the presence of inhibitors may be quantitatively or even qualitatively different from that in normally labelled cultures.
These experiments showed that the effects of pepstatin and Z-Phe-Ala-CHN2 were reversible. As ZPhe-Ala-CHN2 forms covalent complexes with thiol proteinases, it may be deduced that recovery of cathepsin B activity results from the production of new molecules of active cathepsin B. Although the effects of the two inhibitors were additive in some conditions, the degree of inhibition obtained was never greater than 45%, in spite of the pretreatment with inhibitor. Because Z-Phe-Ala-CHN2 seems to enter macrophages by pinocytosis (as does pepstatin; Dean, 1979) , its effects are almost certainly exerted on lysosomal proteolysis. Thus the present evidence supports and extends previous work indicating lysosomal participation in macrophage basal proteolysis, and specifically implicates thiol proteinases. Although we have demonstrated inhibition of the enzyme active on Z-Arg-Arg 2-naphthylamide, primarily cathepsin B, it is likely that other thiol proteinases, such as cathepsin L (Kirschke et al., 1977) , are affected also. The maximum inhibition observed, 45%, suggests that a maximum of 55% of macrophage basal proteolysis is non-lysosomal. But, as inhibition of one pathway of degradation may accelerate another, this may well be a considerable overestimate of non-lysosomal proteolysis.
